These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2755215)
21. Antibody responses to survivin and their clinical significance in patients with head and neck cancer. Eto M; Kodama S; Uemura N; Suzuki M Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541 [TBL] [Abstract][Full Text] [Related]
22. p53 autoantibodies as tumor marker in head and neck squamous cell cancer. Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322 [TBL] [Abstract][Full Text] [Related]
23. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Mancuso AA Head Neck; 2003 Jul; 25(7):535-42. PubMed ID: 12808656 [TBL] [Abstract][Full Text] [Related]
24. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065 [TBL] [Abstract][Full Text] [Related]
25. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck. Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107 [TBL] [Abstract][Full Text] [Related]
26. The prognostic value of mononucleated cell levels in cancer patients. Elias EG Md Med J; 1991 Apr; 40(4):267-8. PubMed ID: 2034062 [No Abstract] [Full Text] [Related]
27. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576 [TBL] [Abstract][Full Text] [Related]
28. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma. Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803 [TBL] [Abstract][Full Text] [Related]
29. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer. Kuropkat C; Duenne AA; Herz U; Renz H; Werner JA Neoplasma; 2004; 51(5):375-8. PubMed ID: 15640942 [TBL] [Abstract][Full Text] [Related]
30. Serum cystatin C in patients with head and neck carcinoma. Strojan P; Svetic B; Smid L; Kos J Clin Chim Acta; 2004 Jun; 344(1-2):155-61. PubMed ID: 15149884 [TBL] [Abstract][Full Text] [Related]
31. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK; Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826 [TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm]. Dong W; Xu J; Qiao Z; Wang N; Yu R Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967 [TBL] [Abstract][Full Text] [Related]
33. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Eibling DE; Johnson JT; Wagner RL; Su S Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421 [TBL] [Abstract][Full Text] [Related]
34. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093 [TBL] [Abstract][Full Text] [Related]
35. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months]. Clasen B; Roettger D; Senekowitsch R; Menz E Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877 [TBL] [Abstract][Full Text] [Related]
36. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma. Gourin CG; Moretz WH; Weinberger PM; Xia ZS; Liu Z; Terris DJ; Adam BL Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1125-30. PubMed ID: 18025317 [TBL] [Abstract][Full Text] [Related]
37. Correlation of serum immune-reactive proteins with clinical tumor stage in patients with squamous carcinoma of the head and neck and nasopharyngeal carcinoma. Baskies AM; Chretien PB; Wolf GT; Weiss JF Surg Forum; 1979; 30():516-8. PubMed ID: 538683 [No Abstract] [Full Text] [Related]
38. [Vitamin A level and dark adaptation in patients with tumors]. Daxecker F; Bichler E Klin Monbl Augenheilkd; 1984 Feb; 184(2):112-4. PubMed ID: 6716887 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Dahiya K; Dhankhar R; Madaan H; Singh V; Arora K Ann Clin Lab Sci; 2012; 42(1):94-7. PubMed ID: 22371916 [TBL] [Abstract][Full Text] [Related]
40. Crystallization test for the detection of head and neck cancer. Gulati SP; Sachdeva OP; Sachdeva A; Adlakha RP; Kakkar V ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):283-6. PubMed ID: 7970613 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]